Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

fisetin

Source date not recordedAnalyse record ↗

Supplement with the most evidence of senolytic effect, with many ongoing clinical trials at Mayo.

Modality
supplement
Availability (US)
widely available
Biomarkers
big Dx need; research panels exist but not widely avail; inflammatory blood markers as indirect indicators
Hallmark targeted
senolytic
Kind
rejuvenation
Lifespan.io link
detailed page (no date)
ConsumerLab link
for memory Jul'22
Rodent lifespan
ITP: -5-+7%, -1-+2%
Other papers
many [good review needed]; one on dementias
Clinical trials
25 listed
Tested by ITP
yes
ITP year first tested
2018
ITP median % ↑ (♂, best cohort)
7.00
ITP median % ↑ (♀, best cohort)
1.00
ITP P90 % ↑ (♂, best cohort)
0.00
ITP P90 % ↑ (♀, best cohort)
2.00
ITP sex effect
neither
ITP dose (ppm)
600 ppm; 600 ppm (3 days on/11 days off)
ITP age at start (mo)
20 mo
ITP replicated
no
ITP result status
Published (full stats)

ITP cohort detail (2)

YearCohortDose♂ med♀ med♂ P90♀ P90Citation
2018C2018600 ppm-5%1%0%-1%↗ paper
2018C2018600 ppm (3 days on/11 days off)7%-1%-1%2%↗ paper